EAJAIC

The Eurasian Journal of Anesthesiology and Intensive Care (EAJAIC) is an independent-unbiased, peer-reviewed, "double-blind", and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, differential diagnoses, editorial opinions, letters to the editor, and educational papers in anesthesiology, algology, and intensive care medicine.

EndNote Style
Index
Original Article
Examining the effects of lidocaine and dexmedetomidine on compound action potential in rat sciatic nerve
Aims: Recent interest in Peripheral Regional Blocks (PRB) has increased for surgical and nonsurgical implementations. Lidocaine is frequently preferred in PRBs because of its wide safety margin. The short duration of action limits the use of Lidocaine. Dexmedetomidine is a new-generation adjuvant agent. According to our hypothesis, Dexmedetomidine will prolong the duration of the action of Lidocaine.
Methods: A total of 48 rat sciatic nerves were isolated and electrophysiological recordings were taken from 28. They were then randomly divided into 4 groups as Group Control (C), Group L given 1 mM Lidocaine, Group D given 5 microgram/L Dexmedetomidine, and Group LD given 1 mM Lidocaine and 5 microgram/L Dexmedetomidine. Compound Action Potentials (CAP) were recorded after the stimulation of the nerves. Maximum Depolarization Value (MD, mV), time to Maximum Depolarization (MDT), Area Under the CAP curve (Area, mV.ms), and conduction velocities were calculated separately for Fast-Conducting Fibers (CVF, m/s) and Medium-Slow-Conducting Fibers (CVM, m/s).
Results: In the comparisons of the Areas Under the Curve, significant differences were detected for Group C and Group LD (P=0.001). In the comparisons of CVF values, significant differences were detected for Group C with Group L and Group LD (p=0.007, p=0.000). In the comparisons of Group L and Group LD (p=0.002). In the comparisons of CVM values, significant differences were detected for Group C with Group L and Group LD (p=0.000, p=0.000, respectively). Significant differences were detected between Group L, and Group LD (p=0.009).
Conclusion: Results were found showing that perineural Dexmedetomidine when added to Lidocaine as an adjuvant agent, increased the number of fibers that developed block and decreased conduction velocities. These results might indicate that Dexmedetomidine may increase the duration of the block.


1. Wu D, Patil A. Minimising complications and improving the success of peripheral regional blockade. Br J Hosp Med. 2022;83(10):1-10. doi:10. 12968/hmed.2022.0304
2. Fallon F, Moorthy A, Skerritt C, Crowe GG, Buggy DJ. Latest Advances in regional anaesthesia. Medicina (Mex). 2024;60(5):735. doi:10.3390/medicina60050735
3. Lee HH, Kwon HM, Lee WS, Yang IH, Choi YS, Park KK. Effectiveness of ERAS (enhanced recovery after surgery) protocol via peripheral nerve block for total knee arthroplasty. J Clin Med. 2022;11(12):3354. doi:10.3390/jcm11123354
4. Chen Z, Liu Z, Feng C, Jin Y, Zhao X. Dexmedetomidine as an adjuvant in peripheral nerve block. Drug Des Devel Ther. 2023;17:1463-1484. doi:10. 2147/DDDT.S405294
5. Hopkins PM. Does regional anaesthesia improve outcome? Br J Anaesth. 2015;115(Suppl 2):ii26-ii33. doi:10.1093/bja/aev377
6. Ae B, R F, Jl H, Ms A. Continuous peripheral nerve block compared with single-injection peripheral nerve block: a systematic review and meta-analysis of randomized controlled trials. Reg Anesth Pain Med [İnternet]. 2012 Dec [cited 2024 Nov 2];37(6). Available from: https://pubmed.ncbi.nlm.nih.gov/23080349/
7. Ilfeld BM. Continuous peripheral nerve blocks: an update of the published evidence and comparison with novel, alternative analgesic modalities. Anesth Analg. 2017;124(1):308-335. doi:10.1213/ANE.0000000000001581
8. Desai N, Kirkham KR, Albrecht E. Local anaesthetic adjuncts for peripheral regional anaesthesia: a narrative review. [cited 2024 Jul 24]; Available from: https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/anae.15245
9. Cata JP, Ramirez MF, Velasquez JF, et al. Lidocaine stimulates the function of natural killer cells in different experimental settings. Anticancer Res. 2017;37(9):4727-4732. doi:10.21873/anticanres.11879
10. Grotowska M, Gozdzik W. Intraoperative intravenous infusion of lidocaine increases total and small vessel densities of sublingual microcirculation: a randomized prospective pilot study. J Int Med Res. 2023;51(11): 3000605231209820. doi:10.1177/03000605231209820
11. Karlsdottir BR, Zhou PP, Wahba J, et al. Male gender, smoking, younger age, and preoperative pain found to increase postoperative opioid requirements in 592 elective colorectal resections. Int J Colorectal Dis. 2022;37(8):1799-1806. doi:10.1007/s00384-022-04208-5
12. Choi GJ, Ahn EJ, Lee OH, Kang H. Effects of a BMI1008 mixture on postoperative pain in a rat model of incisional pain. PLoS ONE. 2021;16(9)e0257267. doi:10.1371/journal.pone.0257267
13. Moldovan M, Lange KHW, Aachmann-Andersen NJ, Kjær TW, Olsen NV, Krarup C. Transient impairment of the axolemma following regional anaesthesia by lidocaine in humans. J Physiol. 2014;592(Pt 13):2735. doi:10. 1113/jphysiol.2014.270827
14. Shanthanna H, Weinberg G. Intravenous lidocaine, regional blockade, or both: considerations for multiple interventions involving local anaesthetics. Br J Anaesth. 2021;127(4):497-501. doi:10.1016/j.bja.2021.04.024
15. Bilotta F, Pugliese F. The evolving clinical use of dexmedetomidine. The Lancet. 2020;396(10245):145-147. doi:10.1016/S0140-6736(20)30902-8
16. Singh N, Gupta S, Kathuria S. Dexmedetomidine vs dexamethasone as an adjuvant to 0.5% ropivacaine in ultrasound-guided supraclavicular brachial plexus block. J Anaesthesiol Clin Pharmacol. 2020;36(2):238. doi:10.4103/joacp.JOACP_176_19
17. Rancourt MP, Albert NT, Côté M, Létourneau DR, Bernard PM. Posterior tibial nerve sensory blockade duration prolonged by adding dexmedetomidine to ropivacaine. Anesth Analg. 2012;115(4):958. doi:10. 1213/ANE.0b013e318265bab7
18. Brummett CM, Hong EK, Janda AM, Amodeo FS, Lydic R. Perineural dexmedetomidine added to ropivacaine for sciatic nerve block in rats prolongs the duration of analgesia by blocking the hyperpolarization-activated cation current. Anesthesiology. 2011;115(4):836-843. doi:10.1097/ALN.0b013e318221fcc9
19. Kroin JS, Buvanendran A, Beck DR, Topic JE, Watts DE, Tuman KJ. Clonidine prolongation of lidocaine analgesia after sciatic nerve block in rats is mediated via the hyperpolarization-activated cation current, not by α-adrenoreceptors. Anesthesiology. 2004;101(2):488-494. doi:10. 1097/00000542-200408000-00031
20. Han M, Kang F, Yang C, et al. Comparison of adrenaline and dexmedetomidine in improving the cutaneous analgesia of mexiletine in response to skin pinpricks in rats. Pharmacology. 2020;105(11-12):662-668. doi:10.1159/000506487
21. Peña E, Pelot NA, Grill WM. Computational models of compound nerve action potentials: efficient filter-based methods to quantify effects of tissue conductivities, conduction distance, and nerve fiber parameters. PLOS Comput Biol. 2024;20(3):e1011833. doi:10.1371/journal.pcbi.1011833
22. Barrois R, Barnerias C, Deladrière E, et al. A new score combining compound muscle action potential (CMAP) amplitudes and motor score is predictive of motor outcome after AVXS-101 (Onasemnogene Abeparvovec) SMA therapy. Neuromuscul Disord. 2023;33(4):309-314. doi: 10.1016/j.nmd.2023.02.004
23. Taylan SB, Bariskaner H. Effects of dexmedetomidine and dexketoprofen on the conduction block of rat sciatic nerve. Neural Regen Res. 2020;15(5):929. doi:10.4103/1673-5374.268926
24. Kincaid JC, Minnick KA, Pappas S. A model of the differing change in motor and sensory action potentials over distance. Muscle Nerve. 1988; 11(4):318-323. doi:10.1002/mus.880110407
25. Dalkiliç N, Pehlivan F. Comparison of fiber diameter distributions deduced by modeling compound action potentials recorded by extracellular and suction techniques.Int J Neurosci. 2002;112(8):913-930. doi:10. 1080/00207450290025923
26. Marolf V, Ida KK, Siluk D, Struck-Lewicka W, Markuszewski MJ, Sandersen C. Effects of perineural administration of ropivacaine combined with perineural or intravenous administration of dexmedetomidine for sciatic and saphenous nerve blocks in dogs. 2021 Jun 1 [cited 2024 Nov 11]; Available from: https://avmajournals.avma.org/view/journals/ajvr/82/6/ajvr.82.6.449.xml
27. Ouchi K, Koga Y, Nakao S, Sugiyama K. Dexmedetomidine dose-dependently enhances local anesthetic action of lidocaine. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg. 2014;72(3):474-480. doi:10. 1016/j.joms.2013.09.038
28. Kosugi T, Mizuta K, Fujita T, Nakashima M, Kumamoto E. High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without α2 adrenoceptor activation. Br J Pharmacol. 2010;160(7):1662-1676. doi:10.1111/j.1476-5381.2010.00833.x
29. Chen BS, Peng H, Wu SN. Dexmedetomidine, an α2-adrenergic agonist, inhibits neuronal delayed-rectifier potassium current and sodium current. Br J Anaesth. 2009;103(2):244-254. doi:10.1093/bja/aep107
30. Ishii H, Kohno T, Yamakura T, Ikoma M, Baba H. Action of dexmedetomidine on the substantia gelatinosa neurons of the rat spinal cord. Eur J Neurosci. 2008;27(12):3182-3190. doi:10.1111/j.1460-9568.2008.06260.x
31. Oda A, Iida H, Tanahashi S, Osawa Y, Yamaguchi S, Dohi S. Effects of α2-adrenoceptor agonists on tetrodotoxin-resistant Na+ channels in rat dorsal root ganglion neurons*. Eur J Anaesthesiol EJA. 2007;24(11):934. doi:10. 1017/S0265021507000543
32. Dalkilic N, Tuncer S, Burat I. Dexmedetomidine augments the effect of lidocaine: power spectrum and nerve conduction velocity distribution study. BMC Anesthesiol. 2015;15(1):24. doi:10.1186/s12871-015-0009-9
33. Rushton WA. A theory of the effects of fibre size in medullated nerve.J Physiol. 1951;115(1):101-122. doi:10.1113/jphysiol.1951.sp004655
34. Waxman SG. Determinants of conduction velocity in myelinated nerve fibers. Muscle Nerve. 1980;3(2):141-150. doi:10.1002/mus.880030207
35. Ikeda M, Oka Y. The relationship between nerve conduction velocity and fiber morphology during peripheral nerve regeneration. Brain Behav. 2012; 2(4):382-390. doi:10.1002/brb3.61
36. Butterworth JF, Strichartz GR. The alpha 2-adrenergic agonists clonidine and guanfacine produce tonic and phasic block of conduction in rat sciatic nerve fibers. Anesth Analg. 1993;76(2):295-301.
37. Gaumann DM, Brunet PC, Jirounek P. Clonidine enhances the effects of lidocaine on C-fiber action potential. Anesth Analg. 1992;74(5):719. doi:10. 1213/00000539-199205000-00017
38. Ghaderi K, Rahmani K, Rahmanpanah N, Shami S, Zahedi F, Nasseri K. Comparison of lidocaine-dexmedetomidine and lidocaine-saline on the characteristics of the modified forearm bier block: a clinical trial. J Anaesthesiol Clin Pharmacol. 2021;37(4):610-615. doi:10.4103/joacp.JOACP_54_20
39. Hu X, Li J, Zhou R, et al. Dexmedetomidine added to local anesthetic mixture of lidocaine and ropivacaine enhances onset and prolongs duration of a popliteal approach to sciatic nerve blockade. Clin Ther. 2017;39(1):89-97.e1. doi:10.1016/j.clinthera.2016.11.011
40. Abdulatif M, Fawzy M, Nassar H, Hasanin A, Ollaek M, Mohamed H. The effects of perineural dexmedetomidine on the pharmacodynamic profile of femoral nerve block: a dose-finding randomised, controlled, double-blind study. Anaesthesia. 2016;71(10):1177-1185. doi:10.1111/anae.13603
Volume 2, Issue 1, 2025
Page : 18-23
_Footer